Gene · 10645
Papers2,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research Progress on the Effect and Mechanism of Tea Products with Different Fermentation Degrees in Regulating Type 2 Diabetes Mellitus. | Foods | 2024 | 38254521 | PubTator, text mining | PubMed |
| Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD+/SIRT1/AMPK pathway-mediated effects on mitochondrial function and cellular metabolism. | Eur J Med Res | 2024 | 38245795 | PubTator, text mining | PubMed |
| MIIP downregulation drives colorectal cancer progression through inducing peri-cancerous adipose tissue browning. | Cell Biosci | 2024 | 38245780 | PubTator, text mining | PubMed |
| Bioinformatics analysis identifies GLUD1 as a prognostic indicator for clear cell renal cell carcinoma. | Eur J Med Res | 2024 | 38245763 | PubTator, text mining | PubMed |
| Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS). | Respir Res | 2024 | 38218783 | PubTator, text mining | PubMed |
| Unveiling dysregulated lncRNAs and networks in non-syndromic cleft lip with or without cleft palate pathogenesis. | Sci Rep | 2024 | 38200098 | PubTator, text mining | PubMed |
| The 2023 Walter B. Cannon Award Lecture: Mechanisms Regulating Vascular Function and Blood Pressure by the PPARγ-RhoBTB1-CUL3 Pathway. | Function (Oxf) | 2024 | 38196837 | PubTator, text mining | PubMed |
| DEL-1: a promising treatment for AMD-associated ER stress in retinal pigment epithelial cells. | J Transl Med | 2024 | 38195611 | PubTator, text mining | PubMed |
| Advances in invasive micropapillary carcinoma of the breast research: A review. | Medicine (Baltimore) | 2024 | 38181281 | PubTator, text mining | PubMed |
| NCPAD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer. | Genes Environ | 2024 | 38172945 | PubTator, text mining | PubMed |
| JS-K activates G2/M checkpoints through the DNA damage response and induces autophagy via CAMKKβ/AMPKα/mTOR pathway in bladder cancer cells. | J Cancer | 2024 | 38169515 | PubTator, text mining | PubMed |
| Anoikis-related CTNND1 is associated with immuno-suppressive tumor microenvironment and predicts unfavorable immunotherapeutic outcome in non-small cell lung cancer. | J Cancer | 2024 | 38169514 | PubTator, text mining | PubMed |
| Synthesis and biological evaluation of 2'-hydroxychalcone derivatives as AMPK activators. | Bioorg Chem | 2024 | 38141328 | PubTator, text mining | PubMed |
| Cytomegalovirus-induced inactivation of TSC2 disrupts the coupling of fatty acid biosynthesis to glucose availability resulting in a vulnerability to glucose starvation. | mBio | 2024 | 38117060 | PubTator, text mining | PubMed |
| Host IP3R channels are dispensable for rotavirus Ca2+ signaling but critical for intercellular Ca2+ waves that prime uninfected cells for rapid virus spread. | mBio | 2024 | 38112482 | PubTator, text mining | PubMed |
| Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity. | Cancer Res | 2024 | 38038968 | PubTator, text mining | PubMed |
| Cardioprotective Strategies After Ischemia-Reperfusion Injury. | Am J Cardiovasc Drugs | 2024 | 37815758 | PubTator, text mining | PubMed |
| Ion channel P2X7 receptor in the progression of cancer. | Front Oncol | 2023 | 38273855 | PubTator, text mining | PubMed |
| Current understanding of macrophages in intracranial aneurysm: relevant etiological manifestations, signaling modulation and therapeutic strategies. | Front Immunol | 2023 | 38259443 | PubTator, text mining | PubMed |
| Drug resistance in glioblastoma: from chemo- to immunotherapy. | Cancer Drug Resist | 2023 | 38239396 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10645/papers?page=10